Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Virtual Congress 2021

Registration Programme Abstracts Information for Presenters Congress Officers Exhibition Sponsors Industry Participation Press & Media Contacts

ESMO-TAT-2021-Virtual-Congress-1000x250px

Start date: 01 Mar 2021
End date: 02 Mar 2021

ESMO Targeted Anticancer Therapies Virtual Congress 2021: the Home of Phase I in Oncology

The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies.

It is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.

Organisation

ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
meetings@esmo.org